JPRN-UMIN000044383已完成未知
Efficacy and safety of lemborexant in insomnia patients with nocturia. - Efficacy and safety of lemborexant in insomnia patients with nocturia.
Kyowakai Medical Corporation Kyoritsu Hospital0 个研究点目标入组 30 人开始时间: 2021年5月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with polyuria and nocturnal polyuria. Patients with a history of hypersensitivity to the ingredients of this drug Patients with pyuria or bacteriuria Patients taking other insomnia medications Patients taking CYP3A inhibitors Patients with narcolepsy or cataplexy Patients with sleep apnea syndrome Patients with severe liver dysfunction or severe renal dysfunction
研究者
相似试验
尚未招募
Unknown
se of Lemborexant for Insomnia in Our Clinic: A Retrospective StudyInsomniaJPRN-UMIN000054075Wellness General Clinic1,000
已完成
Unknown
Effects of Lemborexant on insomnia in patients with schizophrenia : A randomized controlled studyInsomnia in patients with schizophreniaJPRN-UMIN000049310Department of Psychiatry, Kurita Hospital, 695 Kurita Nagano-City Nagano, Japan, 380-0921
终止
2 期
The Effects of Lemborexant on the Ability to Sleep During DaytimeShift-Work Sleep DisorderNCT06231641Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal5
招募中
4 期
emborexant for insomnia in patients with psychiatric disorder: A 1-week, open-label studyInsomniaJPRN-UMIN000041321Fujita Health University School of Medicine100
已完成
不适用
Suvorexant for the treatment of insomnia in patients with psychiatric disorderspsychiatric disordersJPRN-UMIN000024941Fujita Health University School of Medicine50